Carna Biosciences (TSE:4572) FCF Margin %: 0.00% (As of Dec. 2025)


TSE:4572 Carna Biosciences Inc TSE:4572
25 GF Score
Price 円314.00
GF Value 円175.60
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Carna Biosciences FCF Margin %?

Carna Biosciences TSE:4572 -3.68% 25 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates TSE:4572 with a GF Score™ of 25/100 and a GF Value™ of 円175.60 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 959 Biotechnology companies, Carna Biosciences ranks worse than 76.64% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Carna Biosciences's Free Cash Flow for the three months ended in Dec. 2025 was 円0.0 Mil. Carna Biosciences's Revenue for the three months ended in Dec. 2025 was 円0.0 Mil. Therefore, Carna Biosciences's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Carna Biosciences's current FCF Yield % is -36.01%.

The historical rank and industry rank for Carna Biosciences's FCF Margin % or its related term are showing as below:

TSE:4572' s FCF Margin % Range Over the Past 10 Years
Min: -744.25   Med: -97.51   Max: 44.76
Current: -744.25

During the past 13 years, the highest FCF Margin % of Carna Biosciences was 44.76%. The lowest was -744.25%. And the median was -97.51%.

TSE:4572's FCF Margin % is ranked worse than
76.64% of 959 companies
in the Biotechnology industry
Industry Median: -84.65 vs TSE:4572: -744.25

Carna Biosciences FCF Margin % Related Terms

Carna Biosciences FCF Margin % Historical Data

* Premium members only.

The historical data trend for Carna Biosciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carna Biosciences FCF Margin % Chart

Carna Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -78.23 -60.17 -103.88 -218.14 -374.51

Carna Biosciences Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

TSE:4572 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Carna Biosciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Carna Biosciences FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Carna Biosciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Carna Biosciences's FCF Margin % falls into.


TSE:4572
25GF Score
Carna Biosciences Inc TSE:4572
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carna Biosciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Carna Biosciences's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-2168.643/579.057
=-374.51 %

Carna Biosciences's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Carna Biosciences (TSE:4572) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Carna Biosciences and its competitors. According to the industry distribution chart, Carna Biosciences ranks #735 out of 959 companies in the Biotechnology industry, placing it in the top 76.6%.
Is Carna Biosciences' FCF Margin % too high?
Carna Biosciences' current FCF Margin % is 0.00%. Based on the distribution chart, Carna Biosciences ranks #735 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Carna Biosciences has a GF Score™ of 25/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Carna Biosciences' FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Carna Biosciences ranks #735 out of 959 companies for FCF Margin %. This places Carna Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Carna Biosciences and its competitors. Carna Biosciences's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carna Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Carna Biosciences (TSE:4572) is currently considered Significantly Overvalued. The stock's GF Value™ is 円175.60, compared to a current price of 円314.00 — trading 78.8% above its estimated fair value. The current FCF Margin % is 0.00%. Carna Biosciences' overall GF Score™ is 25/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Carna Biosciences (TSE:4572), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Carna Biosciences (TSE:4572) Overvalued in 2026?

Based on GuruFocus' analysis, Carna Biosciences stock appears to be overvalued. The current stock price of 円314.00 is trading 78.8% above its estimated GF Value™ of 円175.60. GuruFocus considers Carna Biosciences to be Significantly Overvalued.

Key valuation signals for TSE:4572:

  • FCF Margin %: 0.00%
  • GF Value™: 円175.60 vs. price of 円314.00 (78.8% above fair value)
  • GF Score™: 25/100 with 6 warning signs

No single metric tells the full story. See the TSE:4572 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Carna Biosciences Business Description

Address BMA 3F 1-5-5 Minatojima-Minamimachi, Kobe, JPN, 650-0047
Carna Biosciences Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines for the treatment of cancer and inflammatory diseases using own kinase drug discovery platform, QuickScout.
25GF Score

Get the complete analysis for TSE:4572

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円314.00
Price
円175.60
GF Value